Resources

Explore our extensive resources to uncover more about RCA's expertise in life sciences consulting.

Content Type

Segment

Industries

Published Articles

Audits, Inspections, and CDMOs

Preparing CDMOs and Sponsors for Regulatory Inspections For contract development and manufacturing organizations (CDMOs), navigating regulatory inspections can become complex when multiple clients have different specifications, requirements, and expectations. While...
Read More about Audits, Inspections, and CDMOs

Published Articles

Ask the Expert: Commenting on Draft Regulations

In this episode of the Ask the Expert video series published by Pharmaceutical Technology®, Susan J. Schniepp, Regulatory Compliance Associates, and Siegfried Schmitt, Parexel, give their opinions on why those...
Read More about Ask the Expert: Commenting on Draft Regulations

Published Articles

Effectively Using Contamination Control Strategies

Developing an Effective Contamination Control Strategy In this article, RCA expert and Susan J. Schniepp of Regulatory Compliance Associates (RCA), a Nelson Labs company, discuss how contamination control strategies (CCSs)...
Read More about Effectively Using Contamination Control Strategies

Published Articles

Guidance on Quality Culture Standards

In this article published by Pharmaceutical Technology®, Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discuss PDA/ANSI Standard 06-2025:...
Read More about Guidance on Quality Culture Standards

Published Articles

Ask the Expert: Quality Control Units

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how...
Read More about Ask the Expert: Quality Control Units

Published Articles

Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR...
Read More about Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance